A vast majority of the current industry deficiencies which have led to isolated 483s, Warning Letters and Consent Decrees are the result of deficient technical documentation of the production processes for both injectables, devices and solid dosages.
Batch Production Record and Device History Record Review and Quality Assessment - Webinar By GlobalCompliancePanel
4 April 2013, Fremont, United States
Introduction
Venue
Online Training
Livermore Common, Online Training, California, Fremont, 94539, United States
Useful links
Organised by
GlobalCompliancePanel
Contact information
Related events
New Zealand Institute of Chemistry Conference 2024 (NZIC-24)
24 November 2024 14:00 - 28 November 2024 14:00, Dunedin, New Zealand
Drugging the Multimorbidity Associated with Ageing
17 January 2025 09:30-17:00, London, United Kingdom
Future Labs Live Basel
27 May 2025 09:00 - 28 May 2025 17:00, Basel, Switzerland
European Glycoscience Community Webinar Series
25 January 2024 15:00 - 19 December 2024 18:00
Search
Advertisement
Spotlight
Explore
Membership
